These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12929709)

  • 21. Alcohol use and risk taking among regular ecstasy users.
    Breen C; Degenhardt L; Kinner S; Bruno R; Jenkinson R; Matthews A; Newman J
    Subst Use Misuse; 2006; 41(8):1095-109. PubMed ID: 16798678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
    Parrott AC; Buchanan T; Scholey AB; Heffernan T; Ling J; Rodgers J
    Hum Psychopharmacol; 2002 Aug; 17(6):309-12. PubMed ID: 12404677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The agony with ecstasy: lessons from a recent rave.
    Hoo GW
    J Intensive Care Med; 2013; 28(4):259-61. PubMed ID: 22914795
    [No Abstract]   [Full Text] [Related]  

  • 24. The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion.
    Krotulski AJ; Mohr ALA; Fogarty MF; Logan BK
    J Anal Toxicol; 2018 Oct; 42(8):544-553. PubMed ID: 30371847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA; Rosenberg H
    Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ; Bruno R
    Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study.
    Rodgers J; Buchanan T; Pearson C; Parrott AC; Ling J; Hefferman TM; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):437-46. PubMed ID: 16174668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
    Rodgers J; Buchanan T; Scholey AB; Heffernan TM; Ling J; Parrott AC
    J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.
    Grigg J; Barratt MJ; Lenton S
    Drug Alcohol Rev; 2018 Nov; 37(7):851-855. PubMed ID: 30392182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
    Davis AK; Rosenberg H
    J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy.
    Curran HV; Robjant K
    J Psychopharmacol; 2006 May; 20(3):425-31. PubMed ID: 16574717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. There's something about Molly: The underresearched yet popular powder form of ecstasy in the United States.
    Palamar JJ
    Subst Abus; 2017; 38(1):15-17. PubMed ID: 27925866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ecstasy and drug consumption patterns: a Canadian rave population study.
    Gross SR; Barrett SP; Shestowsky JS; Pihl RO
    Can J Psychiatry; 2002 Aug; 47(6):546-51. PubMed ID: 12211882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. It's a rave new world: rave culture and illicit drug use in the young.
    Rome ES
    Cleve Clin J Med; 2001 Jun; 68(6):541-50. PubMed ID: 11405616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pills and pints: risky drinking and alcohol-related harms among regular ecstasy users in Australia.
    Kinner SA; George J; Johnston J; Dunn M; Degenhardt L
    Drug Alcohol Rev; 2012 May; 31(3):273-80. PubMed ID: 21919977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns and perceptions of ecstasy use among young, low-income women.
    Wu ZH; Holzer CE; Breitkopf CR; Grady JJ; Berenson AB
    Addict Behav; 2006 Apr; 31(4):676-85. PubMed ID: 16005160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.